In terms of continuously evolving market and fast developing healthcare system of the country the pharmaceuticals and healthcare companies encounter numerous challenges such as adherence to government regulations, consideration of local and international tax and customs regulations, and all types of commercial issues including competition matters, parallel importation practice, disputes over intellectual property, anti-monopoly and other key issues.
We provide integrated legal advice to a range of companies in Pharmaceuticals & Healthcare sector in Kazakhstan and CIS countries.
Our knowledge of local business environment and clear understanding of our clients’ business and legal needs help us to add real value to our clients at all stages of projects, providing them with practicable and legally robust solutions.
Review of compliance with mandatory norms of Georgian legislation and making changes to the draft agreement on marketing, sales and distribution;
Legal support in registration of pharmaceuticals;
Advising on the issues of notifying the competent state authority on reactions to medicines;
Advising on the regulation of advertising of medicines;
Advising on the registration of medicines and trademarks;
Advising on the registration and import of pharmaceuticals and medical equipment;
Advising on the localisation of pharmaceuticals;
Advising on the statutory requirements for medical equipment installation and repair works;
Legal support at all implementation stages of a PPP project: licensing, land regulations, construction, customs, general corporate issues, supply of pharmaceuticals, lease of state property, health regulation and contract law issues.
Advising a manufacturer of medical equipment on localisation of production in Russia;
Providing legal support to a medical equipment manufacturer;
Advising on the protection and processing of personal data and trade secrets;
Advising pharmaceutical companies on labour law, trademark protection, as well as advertising and public procurement legislation;
Advising an international group of companies on the business reorganisation in Russia;
Advising on the statutory requirements for securities market and joint-stock companies. Representing interests before federal authorities.
The Board of the Eurasian Economic Commission (EEC) approved on 29 January 2019 the Recommendations on the Guidelines for the Selection of Trade Names of Medicinal Products and the Guidelines for Manufacturing of Finished Dosage Forms of Medicinal Products in order to eliminate differences in the requirements for the manufacturing of finished dosage forms of medicines in Eurasian Member States Economic Union (EAEU).
45 Rockefeller Plaza Suite 2000 New York, NY 10111
+1 (212) 332 3299; +1 (646) 387 4757
Follow us on social media
Subscribe to our newsletter to get the latest news
© 1992-2019 GRATA International. All rights reserved